Myeloperoxidase and carbonyl proteins: promising markers for non-invasive monitoring of graft rejection after heart transplantation.

@article{Koestenbauer2010MyeloperoxidaseAC,
  title={Myeloperoxidase and carbonyl proteins: promising markers for non-invasive monitoring of graft rejection after heart transplantation.},
  author={Sonja Koestenbauer and Philipp Stiegler and Vanessa Stadlbauer and Ursula Mayrhauser and Bettina Leber and Martin J. Schweiger and Andrae Wasler and Guenther Prenner and Michael Sereinigg and Sieglinde Zelzer and Tatjana Stojakovi{\'c} and Michael M Scarpatetti and Antonia Griesbacher and Joachim F. Greilberger and Karlheinz Tscheliessnigg},
  journal={The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation},
  year={2010},
  volume={29 12},
  pages={1352-7}
}
BACKGROUND After heart transplantation (HTx), endomyocardial biopsy (EMB) is currently the standard method to diagnose acute graft rejection. A non-invasive marker of rejection would be desirable as an alternative or to permit more selective use of the costly and invasive EMB. METHODS In this retrospective study, outcomes of routinely taken EMBs were used to select 28 patients after HTx EMB Grade 0R (8 patients), 1R (9 patients) or 2R (11 patients). For these patients, myeloperoxidase (MPO… CONTINUE READING